Search results
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 3 days ago(NYSE:MRK), it is important to understand the ownership structure of the business. We can see that...
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 2 days agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing ...
MRK Stock Sees Decline of Approximately
Knox Daily· 2 days agoUpon closing the transaction, the insider’s holdings decreased to 38,291 shares, worth approximately $6.67 million. As published in a research note from Societe Generale on March 11, 2024, & ...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 5 days agoYou can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Merck & Co., Inc....
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks· 5 days agoInc. (AMZN Quick QuoteAMZN - Free Report) , The Goldman Sachs Group Inc. (GS Quick QuoteGS - Free Report) and Merck & Co< ...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 21 hours agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Scott Black's Strategic Moves in Q4 2023: Spotlight on WR Berkley Corp
GuruFocus.com via Yahoo Finance· 5 days agoThe Walt Disney Co (NYSE:DIS) with 15,767 shares, representing about 1.3% of the portfolio, valued...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WPRI Providence· 1 day agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly ...
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.53% By Investing.com
Investing.com· 2 days agoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.53%
Two local RNA-focused biotechs merge, plan to go public 'at some point' - Boston Business Journal
The Business Journals· 1 day agoMunshi has experience running larger public companies, having previously led Arena Pharmaceuticals ...
